L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro

Virology. 2004 Sep 1;326(2):203-19. doi: 10.1016/j.virol.2004.06.005.

Abstract

The human immunodeficiency virus (HIV) integrase (IN) must covalently join the viral cDNA into a host chromosome for productive HIV infection. l-Chicoric acid (l-CA) enters cells poorly but is a potent inhibitor of IN in vitro. Using quantitative real-time polymerase chain reaction (PCR), l-CA inhibits integration at concentrations from 500 nM to 10 microM but also inhibits entry at concentrations above 1 microM. Using recombinant HIV IN, steady-state kinetic analyses with l-CA were consistent with a noncompetitive or irreversible mechanism of inhibition. IN, in the presence or absence of l-CA, was successively washed. Inhibition of IN diminished, demonstrating that l-CA was reversibly bound to the protein. These data demonstrate that l-CA is a noncompetitive but reversible inhibitor of IN in vitro and of HIV integration in vivo. Thus, l-CA likely interacts with amino acids other than those which bind substrate.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetoacetates / pharmacology
  • Binding Sites
  • Caffeic Acids / pharmacology*
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Echinacea*
  • HIV Integrase / chemistry
  • HIV Integrase / genetics
  • HIV Integrase / metabolism*
  • HIV Integrase Inhibitors / pharmacology*
  • HIV-1 / drug effects*
  • HIV-1 / enzymology
  • Humans
  • Kinetics
  • Mutation
  • Polymerase Chain Reaction
  • Pyrroles / pharmacology
  • Succinates / pharmacology*
  • Virus Integration / drug effects*

Substances

  • Acetoacetates
  • Caffeic Acids
  • HIV Integrase Inhibitors
  • L 731988
  • Pyrroles
  • Succinates
  • HIV Integrase
  • chicoric acid